Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghulam J Mufti

Showing results (161-170 of 224) with videos related to

Pageof 23
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2016
Mixed T Cell Chimerism After Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using an Alemtuzumab-Containing Regimen Is Shaped by Persistence of Recipient CD8 T CellsFrancesco Grimaldi, Victoria Potter, Pilar Perez-Abellan, et al.
Leukemia|March 5, 2021
Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemiaBruno Fattizzo, Robin Ireland, Alan Dunlop, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2013
Long-term outcomes of alemtuzumab-based reduced-intensity conditioned hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myelogenous leukemia secondary to myelodysplastic syndromeVictoria T Potter, Pramila Krishnamurthy, Linda D Barber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2012
Topography, clinical, and genomic correlates of 5q myeloid malignancies revisitedAndres Jerez, Lukasz P Gondek, Anna M Jankowska, et al.
Blood|December 6, 2011
Functional characterization of CD4+ T cells in aplastic anemiaShahram Kordasti, Judith Marsh, Sufyan Al-Khan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 26, 2012
Outcome of donor lymphocyte infusion after T cell-depleted allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndromesPramila Krishnamurthy, Victoria T Potter, Linda D Barber, et al.
Blood|February 3, 2011
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignanciesRamon V Tiu, Lukasz P Gondek, Christine L O'Keefe, et al.
Blood Advances|July 16, 2025
Immune cells display an abnormal maturation and a pro-inflammatory profile in telomere biology disordersWillian R Gomes, Shan Hama, Giorgio Napolitani, et al.
European Journal of Haematology|May 2, 2018
Alemtuzumab vs anti-thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioningMarie Robin, Kavita Raj, Sylvie Chevret, et al.
Blood Advances|October 25, 2019
Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 yearsVipul Sharad Sheth, Victoria Potter, Shreyans A Gandhi, et al.
Pageof 23

Showing results (161-170 of 224) with videos related to

Sort By:
Pageof 23
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2016
Mixed T Cell Chimerism After Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using an Alemtuzumab-Containing Regimen Is Shaped by Persistence of Recipient CD8 T CellsFrancesco Grimaldi, Victoria Potter, Pilar Perez-Abellan, et al.
Leukemia|March 5, 2021
Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemiaBruno Fattizzo, Robin Ireland, Alan Dunlop, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2013
Long-term outcomes of alemtuzumab-based reduced-intensity conditioned hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myelogenous leukemia secondary to myelodysplastic syndromeVictoria T Potter, Pramila Krishnamurthy, Linda D Barber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2012
Topography, clinical, and genomic correlates of 5q myeloid malignancies revisitedAndres Jerez, Lukasz P Gondek, Anna M Jankowska, et al.
Blood|December 6, 2011
Functional characterization of CD4+ T cells in aplastic anemiaShahram Kordasti, Judith Marsh, Sufyan Al-Khan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 26, 2012
Outcome of donor lymphocyte infusion after T cell-depleted allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndromesPramila Krishnamurthy, Victoria T Potter, Linda D Barber, et al.
Blood|February 3, 2011
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignanciesRamon V Tiu, Lukasz P Gondek, Christine L O'Keefe, et al.
Blood Advances|July 16, 2025
Immune cells display an abnormal maturation and a pro-inflammatory profile in telomere biology disordersWillian R Gomes, Shan Hama, Giorgio Napolitani, et al.
European Journal of Haematology|May 2, 2018
Alemtuzumab vs anti-thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioningMarie Robin, Kavita Raj, Sylvie Chevret, et al.
Blood Advances|October 25, 2019
Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 yearsVipul Sharad Sheth, Victoria Potter, Shreyans A Gandhi, et al.
Pageof 23